Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
about
Recurrence and Treatment after Renal Transplantation in Children with FSGSGenetic causes of focal segmental glomerulosclerosis: implications for clinical practiceA retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation.Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severityMutational analysis in podocin-associated hereditary nephrotic syndrome in Polish patients: founder effect in the Kashubian populationGenetics of steroid-resistant nephrotic syndrome: a review of mutation spectrum and suggested approach for genetic testing.NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum.Steroid-resistant nephrotic syndrome: impact of genetic testing.Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing.Recurrence of idiopathic focal segmental glomerulosclerosis after kidney transplantation: experience of a Korean tertiary center.Familial FSGS.The amino acid mutations of the podocin in proteinuria: a meta-analysis.Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible.Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutationR229Q Polymorphism of NPHS2 Gene in Group of Iraqi Children with Steroid-Resistant Nephrotic SyndromeRare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomicsSteroid-resistant nephrotic syndrome with mutations in NPHS2 (podocin): report from a three-generation familyClinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis.Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.Is the red cell distribution width strong predictor for treatment response in primary glomerulonephritides?A molecular genetic analysis of childhood nephrotic syndrome in a cohort of Saudi Arabian families.Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.Truncating Wilms Tumor Suppressor Gene 1 Mutation in an XX Female with Adult-Onset Focal Segmental Glomerulosclerosis and Streak Ovaries: A Case Report.Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome
P2860
Q26746985-C1C3FDB2-0BB9-43BA-AE4C-064A88D1BBDFQ26822256-09C391F8-67CE-40B6-A5FE-E0F20126B761Q34596244-5BA3FF86-717B-4692-9FE0-CC02FF25CA89Q35099840-C53B751C-DE48-4F49-9CC1-AD60A5407B9BQ35959709-526EEF9C-245D-4FAD-BA5D-2AD24B42DB24Q37039388-3FF8F440-AFA7-4C53-9DAA-31F8777814EEQ38114930-AF7E6FD9-25FD-4957-B96A-A9DABAA41A8CQ38162417-C3036F72-85C8-472A-B440-91EFFCEBB282Q38177662-B5FEE463-2FDA-4CBD-A0CA-92C7074285A7Q38193693-67A95C07-9D78-4E0C-8B1B-FCBBC73AD279Q38209829-81FCC646-EC5B-411A-B0E3-4590E975C8B9Q38244354-44F280F0-58D7-4159-920D-4F372EE3DFE8Q40695800-24B4254D-A313-4E07-82A7-FDC568149C6DQ41027140-7C034C40-0DBF-4453-AF5D-A6B64B3E4487Q41993865-BD75D105-5586-4496-97F0-1608215329DCQ42281076-0A1E9395-CAC2-4F87-929A-784C939E4A2EQ42368363-29FBFD49-9C0B-46DC-B634-94AA0B54BCDAQ42676659-9D89B8BA-CED2-4BCB-A693-7E7D52AE5A9CQ42726858-31FAD5B0-04D9-41D3-B850-C1375DB6EF81Q43877559-71656448-72D7-4FE5-9E78-47E31E86D3E5Q47357418-DBE17A26-D558-4212-81A4-08BD1821E753Q47935943-5B88FF7E-91E6-4733-8FF7-82CB6A85CB54Q48090049-D40146EB-B040-44C6-9086-2D3232BACAEBQ50468616-6118ADA8-DF5C-45ED-AE6C-2A2457A06E00Q51063406-6BF70F12-2A18-4966-B2CB-C19F9BF56C6AQ51163489-89C90D84-294C-4C20-AE12-2415555774D5Q52715295-B63E950A-63A9-45F3-A449-E5716F11A6CDQ53016525-11245C58-E49D-490E-AD33-EEEF3DA3D8A0Q57203706-7231588B-8B21-45EC-8ACB-D05D1C1A587B
P2860
Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@ast
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@en
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@nl
type
label
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@ast
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@en
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@nl
prefLabel
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@ast
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@en
Clinical value of NPHS2 analys ...... -resistant nephrotic syndrome.
@nl
P2093
P2860
P50
P356
P1476
Clinical value of NPHS2 analys ...... d-resistant nephrotic syndrome
@en
P2093
Bárbara Tazón-Vega
FSGS Spanish Study Group
Isabel Giménez
José Ballarín
María Ángeles Cobo
Patricia Ruíz
Rafael García-Maset
Sheila Santín
P2860
P304
P356
10.2215/CJN.03770410
P577
2010-10-14T00:00:00Z